
Patients Lived Longer on a New Lung Cancer Drug Than on the Standard One, Its Maker Says
Akeso has disclosed the survival figures behind a lung cancer result it announced without them. At the 2026 World Conference on Lung Cancer, the company reported that patients given its drug…










